| Fanconi anemia: myelodysplasia as a predictor of outcome BP Alter, JP Caruso, RA Drachtman, T Uchida, GVN Velagaleti, ... Cancer genetics and cytogenetics 117 (2), 125-131, 2000 | 196* | 2000 |
| Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity RA Drachtman, PD Cole, CB Golden, SJ James, S Melnyk, J Aisner, ... Pediatric hematology and oncology 19 (5), 319-327, 2002 | 143 | 2002 |
| Stroke risk in siblings with sickle cell anemia MC Driscoll, A Hurlet, L Styles, V McKie, B Files, N Olivieri, C Pegelow, ... Blood, The Journal of the American Society of Hematology 101 (6), 2401-2404, 2003 | 135 | 2003 |
| Dyskeratosis congenita: clinical and genetic heterogeneity: report of a new case and review of the literature RA Drachtman, BP Alter Journal of Pediatric Hematology/Oncology 14 (4), 297-304, 1992 | 127 | 1992 |
| Dyskeratosis congenita. RA Drachtman, BP Alter Dermatologic clinics 13 (1), 33-39, 1995 | 105 | 1995 |
| Dyskeratosis congenita. RA Drachtman, BP Alter Dermatologic clinics 13 (1), 33-39, 1995 | 105 | 1995 |
| Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant LA Michaels, M Gurian, T Hegyi, RA Drachtman Pediatrics 114 (3), 703-707, 2004 | 95 | 2004 |
| Dextromethorphan: A Review of N‐methyl‐d‐aspartate Receptor Antagonist in the Management of Pain A Siu, R Drachtman CNS drug reviews 13 (1), 96-106, 2007 | 93 | 2007 |
| Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre … PD Cole, KM McCarten, Q Pei, M Spira, ML Metzger, RA Drachtman, ... The Lancet Oncology 19 (9), 1229-1238, 2018 | 83 | 2018 |
| Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report PD Cole, CL Schwartz, RA Drachtman, PA De Alarcon, L Chen, ... Journal of Clinical Oncology 27 (9), 1456, 2009 | 76 | 2009 |
| Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia S Gurkan, KJ Scarponi, H Hotchkiss, B Savage, R Drachtman Pediatric nephrology 25, 2123-2127, 2010 | 72 | 2010 |
| Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli‐Derived Asparaginase in Children and Adolescents With Acute … LM Vrooman, II Kirov, ZAE Dreyer, M Kelly, N Hijiya, P Brown, ... Pediatric blood & cancer 63 (2), 228-233, 2016 | 63 | 2016 |
| Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer L Lanikova, F Lorenzo, C Yang, H Vankayalapati, R Drachtman, V Divoky, ... Blood, The Journal of the American Society of Hematology 121 (19), 3918-3924, 2013 | 46 | 2013 |
| Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943 NL Seibel, M Krailo, Z Chen, J Healey, PP Breitfeld, R Drachtman, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 45 | 2007 |
| Exacerbation of chronic idiopathic thrombocytopenic purpura following measles-mumps-rubella immunization RA Drachtman, S Murphy, LJ Ettinger Archives of pediatrics & adolescent medicine 148 (3), 326-327, 1994 | 42 | 1994 |
| Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma PD Harker‐Murray, RA Drachtman, DC Hodgson, AR Chauvenet, ... Pediatric Blood & Cancer 61 (4), 579-586, 2014 | 41 | 2014 |
| Staging evaluation and response criteria harmonization (SEARCH) for childhood, adolescent and young adult Hodgkin lymphoma (CAYAHL): methodology statement JE Flerlage, KM Kelly, A Beishuizen, S Cho, PA De Alarcon, U Dieckmann, ... Pediatric blood & cancer 64 (7), e26421, 2017 | 40 | 2017 |
| Phase II trial of oral aminopterin for adults and children with refractory acute leukemia PD Cole, RA Drachtman, AK Smith, S Cate, RA Larson, DS Hawkins, ... Clinical cancer research 11 (22), 8089-8096, 2005 | 37 | 2005 |
| The SCF and c-kit genes in Diamond-Blackfan anemia RA Drachtman, EN Geissler, BP Alter | 34 | 1992 |
| A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's … TM Horton, RA Drachtman, L Chen, PD Cole, K McCarten, S Voss, ... British journal of haematology 170 (1), 118-122, 2015 | 28 | 2015 |
